Risk-free and very successful vaccines are available for 2 viral STIs: hepatitis B and HPV. These vaccines have represented major advancements in STI prevention. By the top of 2023, the HPV vaccine were launched as part of routine immunization programmes in 140countries, principally high- and middle-profits international locations. WHO response https://us.hc6.org/